283 related articles for article (PubMed ID: 12027419)
1. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
[TBL] [Abstract][Full Text] [Related]
2. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
Wong HK; Kammer GM; Dennis G; Tsokos GC
J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
Nambiar MP; Fisher CU; Warke VG; Krishnan S; Mitchell JP; Delaney N; Tsokos GC
Arthritis Rheum; 2003 Jul; 48(7):1948-55. PubMed ID: 12847689
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of interleukin 2 in SLE T cells.
Tenbrock K; Tsokos GC
Int Rev Immunol; 2004; 23(3-4):333-45. PubMed ID: 15204092
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus.
Burgos P; Metz C; Bull P; Pincheira R; Massardo L; Errázuriz C; Bono MR; Jacobelli S; González A
J Rheumatol; 2000 Jan; 27(1):116-27. PubMed ID: 10648027
[TBL] [Abstract][Full Text] [Related]
6. Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients.
Fujii Y; Fujii K; Tanaka Y
Autoimmun Rev; 2006 Feb; 5(2):143-4. PubMed ID: 16431347
[TBL] [Abstract][Full Text] [Related]
7. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.
Fan W; Liang D; Tang Y; Qu B; Cui H; Luo X; Huang X; Chen S; Higgs BW; Jallal B; Yao Y; Harley JB; Shen N
Arthritis Rheum; 2012 Nov; 64(11):3715-25. PubMed ID: 22736314
[TBL] [Abstract][Full Text] [Related]
8. Binding of nuclear proteins to the negative regulatory element of the IL-2 gene in lymphocytes from rheumatic patients.
Flescher E; Vela-Roch N; Talal N; Dang H
Cytokine; 1999 Mar; 11(3):187-91. PubMed ID: 10209065
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of interleukin-2 in human systemic lupus erythematosus.
Katsiari CG; Tsokos GC
Autoimmun Rev; 2006 Feb; 5(2):118-21. PubMed ID: 16431340
[TBL] [Abstract][Full Text] [Related]
12. Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.
Zhang Q; Long H; Liao J; Zhao M; Liang G; Wu X; Zhang P; Ding S; Luo S; Lu Q
J Autoimmun; 2011 Nov; 37(3):180-9. PubMed ID: 22014533
[TBL] [Abstract][Full Text] [Related]
13. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin-2/vaccinia recombinant virus.
Gutierrez-Ramos JC; Andreu JL; Revilla Y; Viñuela E; Martinez C
Nature; 1990 Jul; 346(6281):271-4. PubMed ID: 1973822
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
15. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
[TBL] [Abstract][Full Text] [Related]
16. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
[TBL] [Abstract][Full Text] [Related]
17. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
18. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter.
Gorrill TS; Khalili K
Virology; 2005 Apr; 335(1):1-9. PubMed ID: 15823601
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
20. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus.
Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y
Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]